Author: Banin, I. N.; Budnevsky, A. V.; Grechkin, V. I.; Ovsyannikov, E. S.; Tokmachev, R. E.; Neznamov, O. D.; Savushkina, I. A.
Title: The experience of surfactant therapy in severe covid-19 pneumonia: A case report Cord-id: pxguxpbl Document date: 2021_1_1
ID: pxguxpbl
Snippet: The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with
Document: The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with severe COVID-19. The article provides a description of a case when surfactant therapy was successfully used in a patient with severe COVID-19 pneumonia.(International Journal of Biomedicine. 2021;11(2):177-180.). © 2021, International Medical Research and Development Corporation. All rights reserved.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date